• Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase originally identified for its role in the regulation of glycogen PKR Inhibitor deposition. (cancer-ecosystem.com)
  • In addition to understand the physiological role of GSK-3β (cytosolic Ca2+ concentration) single cells were viewed with a laser-scanning confocal system (FluoView 500 Olympus Tokyo Japan) attached to an PKR Inhibitor upright microscope (BX51WI Olympus). (cancer-ecosystem.com)
  • HLE-B3 cells, maintained in a continuous hypoxic environment (1% oxygen), were treated with SB216763, a specific inhibitor of glycogen synthase kinase-3β (GSK-3β) catalytic activity. (molvis.org)
  • The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and efficacy of 9-ING-41, a potent GSK-3ß inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers. (fredhutch.org)
  • is independently selected from alkyl, aryl, in the preparation of a medicament for the treatment of a disease requiring a GSK-3 inhibitor. (justia.com)
  • Here, we report that a specific glycogen synthase kinase 3 (GSK-3) inhibitor, CHIR99021, can induce the reprogramming of mouse embryonic fibroblasts transduced by only two factors, Oct4 and Klf4. (ca.gov)
  • Our studies suggest that the GSK-3 inhibitor might have a general application to replace transcription factors in both mouse and human reprogramming. (ca.gov)
  • Interestingly, while GT1b enhanced caspase-3 activity, DEVD, a caspase-3 inhibitor, failed to rescue DA neuronal death. (biomedcentral.com)
  • Moreover, a GSK-3β specific inhibitor, L803-mt, attenuated tau phosphorylation and rescued DA neurons from cell death in mesencephalic cultures. (biomedcentral.com)
  • It is a potent GSK-3 inhibitor currently ongoing clinical trials for the treatment of Alzheimer's and progressive supranuclear palsy. (imedix.com)
  • English scientists discovered that the GSK-3 inhibitor stimulates tissue regeneration in damaged teeth. (imedix.com)
  • The technique consists of filling a tooth cavity with a collagen sponge (which is left to biodegrade) and applying a GSK-3 inhibitor drug to the affected area. (imedix.com)
  • In the present study, primary human bone marrow cells were cultured for 12 days in megakaryocyte lineage induction (MKLI) media to induce their differentiation into megakaryocyte (MK) lineage cells, in the presence or absence (+/-) of TWS119, a GSK-3β inhibitor, during MK differentiation from stem cells and subsequent platelet production. (elsevierpure.com)
  • Lithium chloride, an inhibitor of GSK-3β, did not provide additional attenuated NGF levels compared with atrasentan alone. (tmu.edu.tw)
  • Treatment of PC3 cells with the Src inhibitor dasatinib reduced Y216 GSK-3 phosphorylation and inhibited proliferation, invasion and micrometastasis in vitro. (oncotarget.com)
  • The GSK-3, that is the key enzyme is normally showing its actions by various mechanisms that include its phosphorylation, formation of protein complexes, and other cellular distribution and thus it control and directly affects cellular morphology, its growth, mobility and apoptosis of the cell. (scielo.br)
  • The protein inhibits GSK-3-mediated phosphorylation of beta-catenin and positively regulates the Wnt signaling pathway. (nih.gov)
  • 11 12 Nuclear export of NFAT members is facilitated by phosphorylation and several kinases have been suggested to regulate NFAT function including GSK-3 (13) CK1 (14) p38 (15) and JNK1 (16). (cancer-ecosystem.com)
  • With respect to transcription GSK-3 regulates a wide variety of transcription factors including cyclin D1 c-Jun NFATc and β-catenin (13 19 20 In resting cells GSK-3 is constitutively active and its activity is inhibited by various kinases via phosphorylation of a serine residue Ser-21 in GSK-3α and Ser-9 in GSK-3β in response to different stimuli (21). (cancer-ecosystem.com)
  • the GSK-3 catalytic domain thus inhibiting substrate phosphorylation (22). (cancer-ecosystem.com)
  • Of the two isoforms of GSK-3 GSK-3β is a more likely candidate for being an NFATc1 kinase influencing NFATc1 subcellular localization through phosphorylation (13). (cancer-ecosystem.com)
  • GSK-3 is a critical downstream element of the PI3K/Akt cell survival pathway whose activity can be inhibited by Akt-mediated phosphorylation at Ser21 of GSK-3α and Ser9 of GSK-3β (2,3). (cellsignal.com)
  • Here, we show that NEMO phosphorylation by GSK-3β leads to NEMO localization into multivesicular bodies (MVBs). (mdpi.com)
  • Snow AJ, Puri P, Acker-Palmer A, Bouwmeester T, Vijayaraghavan S, Kline D. Phosphorylation-dependent interaction of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (YWHA) with PADI6 following oocyte maturation in mice.Biol Reprod. (kent.edu)
  • Immunostains of human airway sections revealed concordant activation of Akt (reflected in Ser(473) phosphorylation) and of its downstream effector p70(S6Kinase) (reflected in Thr(389) phosphorylation) within airway muscle bundles, but there was no phosphorylation of the alternative Akt downstream target glycogen synthase kinase (GSK) 3β. (nih.gov)
  • In this study, we demonstrate for the first time that GT1b neurotoxicity is accompanied by inactivation of Akt, activation of GSK-3β and increase in tau phosphorylation in mesencephalic DA neurons, both in vivo and in vitro . (biomedcentral.com)
  • In addition, the suppression of ERM phosphorylation by inhibiting phosphoinositide 3-kinase (PI-3K) in the growth cones of DRG axons results in growth cone collapse. (estme.org)
  • Our data show that Src, a non-receptor tyrosine kinase is responsible for Y216 GSK-3 phosphorylation leading to its activation even when Akt is active. (oncotarget.com)
  • Experiments involving mouse embryonic fibroblasts lacking cSrc, Yes and Fyn, as well as Src activity modulation in prostate cancer cells with constitutively active (CA-Src) and dominant negative Src (DN-Src) plasmids demonstrated the integral role of Src in Y216 GSK-3 phosphorylation and activity modulation. (oncotarget.com)
  • Together, we provide novel insight into the Src-mediated Y216 GSK-3 phosphorylation and activation in prostate cancer cells and reveal the potential benefits of targeting Src-GSK-3 axis using drugs such as dasatinib. (oncotarget.com)
  • Small molecule GSK-3B inhibitors are currently undergoing clinical investigation. (providence.org)
  • Glycogen Synthase Kinase Inhibitors " has 18 results in Products. (rndsystems.com)
  • There is tremendous interest in GSK-3 inhibitors as novel therapeutic agents, and selective, small-molecule compounds are rapidly being developed for a broad range of other maladies including diabetes, Alzheimer's disease, stroke, and inflammatory conditions. (psychiatrist.com)
  • We conclude with a discussion of the GSK-3 inhibitors furthest in development and the clinical trials that may emerge. (psychiatrist.com)
  • In the present study, structure-based pharmacophore and ligand-based 3D QSAR, HQSAR and pharmacophore mapping studies have been emphasized to explore the possible structural requirement of this potential kinase inhibitors using a structurally diverse set of compounds. (unboundmedicine.com)
  • Molecular diversity provides an opportunity on wide range of applicability for the GSK-3β inhibitors, and depicts information on the structural and properties requirement for effective binding at the active site selectivity that minimize the side effects with therapeutic benefits. (unboundmedicine.com)
  • TY - JOUR T1 - Exploring Structural and Physicochemical Profiles of Potential GSK-3β Inhibitors Using Structure- and Ligand-Based Modeling Studies. (unboundmedicine.com)
  • Protein regulators of this enzyme include inhibitors I2 (PPP1R2) and I3 (PPP1R11), sds22 (PPP1R7), protein 14-3-3 and a protein kinase, glycogen synthase kinase 3 (GSK-3). (kent.edu)
  • Novel 8-arylated purines as inhibitors of glycogen synthase kinase. (idrblab.net)
  • The non-trivial role of the GSK-3 (glycogen synthase kinase 3) enzyme in a number of diseases is being intensely studied through the development and testing of a new class of drugs - GSK-3 inhibitors. (imedix.com)
  • With the new drug (made of GSK-3 inhibitors) and collagen, scientists were able to induce natural regeneration of dentine to seal off 0.14mm holes in mice's teeth in four to six weeks. (imedix.com)
  • These results advance the understanding of GSK-3B complex signaling network interfacing with key pathways involved in carcinogenesis and immune response. (providence.org)
  • GSK-3 has an essential role in a number of signaling pathways and regulates the function of a diverse number of proteins, notably transcription factors and cytoskeletal elements. (psychiatrist.com)
  • In this perspectives article, we provide an overview of the molecular targets of lithium, focusing on GSK-3-regulated signaling pathways and the important functions of GSK-3 that may have relevance for the treatment of bipolar disorder. (psychiatrist.com)
  • In addition, pretreatment with L-theanine blocked THC-induced downregulation of local GSK-3 (glycogen synthase kinase 3) and Akt signaling pathways directly in the PFC, two biomarkers previously associated with cannabis-related psychiatric risk and subcortical DAergic dysregulation. (bepress.com)
  • Of several of the pathways, glycogen synthase kinase (GSK) 3 provides surfaced as the integration stage and plays an essential function in managing the Nrf2 activity. (mingsheng88.org)
  • Glycogen synthase kinase (GSK)-3, a constitutively active serine-threonine kinase, acts as a key regulator of major signaling pathways, including the Wnt, Hedgehog, and Notch pathways. (elsevierpure.com)
  • The results of the analysis indicated that GSK-3β inhibition during differentiation into MK lineage cells affected factors related to transcription, apoptosis, cell division, cell cycle, blood coagulation, lipid transport, keratin filament, metabolic processes, and the Wnt signaling and transforming growth factor-β signaling pathways. (elsevierpure.com)
  • Phosphorylated Glycogen Synthase Kinase 3 Beta P Gsk3β, supplied by Cell Signaling Technology Inc, used in various techniques. (bioz.com)
  • expression of the catalytically inactive GSK-3β (GSK3β-K85R) or small interfering RNA (siRNA)-mediated GSK-3β silencing enhances osteoclast formation. (cancer-ecosystem.com)
  • We demonstrate here that the kinases Gsk3β and cAMP-dependent protein kinase A (PKA) are novel determinants of IZ formation and cooperate with E(Spl) activity in a dose-dependent manner. (biologists.com)
  • Glycogen synthase kinase-3B (GSK-3B), a serine/threonine kinase, has been implicated in the pathogenesis of many cancers, with involvement in cell cycle regulation, apoptosis, and immune response. (providence.org)
  • GSK-3 is a ubiquitously expressed serine/threonine protein kinase that phosphorylates and inactivates glycogen synthase. (cellsignal.com)
  • GSK 3 is normally a portrayed, active constitutively, proline-directed serine/threonine kinase involved with diverse biophysiological features including glycogen fat burning capacity, embryo development, tissues injury, regeneration and repair, immunomodulation, and redox homeostasis16. (mingsheng88.org)
  • Immunoblot analysis revealed that GT1b inactivates Akt through dephosphorylation at both Ser473 and Thr308, subsequent dephosphorylation of GSK-3β, a substrate of Akt, and hyperphosphorylation of tau, downstream of GSK-3β. (biomedcentral.com)
  • The PI-3K pathway regulates diverse neuronal activities, mainly through the downstream molecule Akt/protein kinase B. In addition to a critical role in neuronal survival12C15, PI3K/Akt signaling has been implicated in dendritic morphogenesis16, neuronal polarity and growth17, synaptogenesis and spinogenesis18, plasticity19, axon establishment, and axon elongation during development by phosphorylating glycogen synthase kinase (GSK)-3, which leads to GSK3 inactivation20C23. (estme.org)
  • Pharmacological inhibition of GSK-3β further confirmed the negative role of GSK-3β in osteoclast formation. (cancer-ecosystem.com)
  • SB216763-treated HLE-B3 cells caused marked inhibition of GSK-3β activity prompting a significant increase in the translocation of cytoplasmic β-catenin to the nucleus. (molvis.org)
  • This indicated that the GSK-3β inhibition affects thrombopoiesis under these conditions with TPO. (elsevierpure.com)
  • To identify the target(s) of GSK-3β inhibition during differentiation into MK lineage cells, we performed a differential gene expression study and subsequent pathway analysis of the large (MK)-sized CD41 (+)/propidium iodide (-) cells cultured in TWS119 (+/-) for 3 days. (elsevierpure.com)
  • These observations suggest that GSK-3β inhibition and TPO treatment affect both megakaryopoiesis and thrombopoiesis in an in vitro differentiation system for primary human bone marrow cells. (elsevierpure.com)
  • Lee, TM , Chang, NC & Lin, SZ 2017, ' Inhibition of infarction-induced sympathetic innervation with endothelin receptor antagonism via a PI3K/GSK-3β-dependent pathway ', Laboratory Investigation , vol. 97, no. 3, pp. 243-255. (tmu.edu.tw)
  • Inhibition of GSK-3 with SB415286 in PC3 cells resulted in impaired motility, proliferation and colony formation. (oncotarget.com)
  • Glycogen synthase kinase-3 (GSK-3) a magic enzyme: it's role in diabetes mellitus and glucose homeostasis, interactions with fluroquionlones. (scielo.br)
  • This disease is mainly regulated by various enzymes and hormones among which Glycogen synthase kinase-3 (GSK-3) is a principle enzyme and insulin is the key hormone regulating it. (scielo.br)
  • Disturbances in the action of GSK-3 enzyme may leads to various disease conditions that include insulin resistance leading to diabetes, neurological disease like Alzheimer's disease and cancer. (scielo.br)
  • Fluoroquinolones are the most common class of drugs that shows dysglycemic effects via interacting with GSK-3 enzyme. (scielo.br)
  • The enzyme glycogen synthase kinase-3 (GSK-3) is a direct target of lithium. (psychiatrist.com)
  • Glycogen synthase kinase-3 (GSK-3) was initially identified as an enzyme that regulates glycogen synthesis in response to insulin (1). (cellsignal.com)
  • The kinase enzyme plays major role in pathological process for the formation of β-amyloid plaques and neurofibrillary tangles in AD. (unboundmedicine.com)
  • More specifically, this is because lithium can inhibit the enzyme GSK-3 (official name: glycogen synthase kinase-3) in your brain and other organs. (lifeextension.com)
  • Sarshad AA, Corcoran M, Al-Muzzaini B, Borgonovo-Brandter L, Von Euler A, Lamont D, Visa N, Percipalle P*. (2014) 'Glycogen synthase kinase (GSK) 3 β phosphorylates and protects nuclear myosin 1c from proteasome-mediated degradation to activate rDNA transcription in early G1 cells. (nyu.edu)
  • Phosphatidylinositol 3-kinase (PI3K)/Akt/glycogen synthase kinase (GSK)-3β signal has been implicated in the regulation of NGF. (tmu.edu.tw)
  • We investigated whether selective ET receptor blockers attenuated cardiac sympathetic reinnervation through restoring PI3K/Akt/GSK-3β activity. (tmu.edu.tw)
  • ET A receptor antagonism is a mediator to attenuate sympathetic hyperinnervation probably through restoration of PI3K/Akt/GSK-3β/ROS signaling pathway, a potential pharmacological target for arrhythmias after infarction. (tmu.edu.tw)
  • Currently, it is unclear how both Akt that inhibits GSK-3 and active GSK-3 are maintained concurrently in tumor cells. (oncotarget.com)
  • GSK-3 has been implicated in the regulation of cell fate in Dictyostelium and is a component of the Wnt signaling pathway required for Drosophila, Xenopus, and mammalian development (4). (cellsignal.com)
  • It has been reported that lung cancer cells exhibit upregulated expression of all key glycolytic enzymes [hexokinase 2 (HK2), phosphofructokinase and pyruvate kinase (PK)] ( 13 ), suggesting that the essential enzymes of the aerobic glycolytic pathway have a critical role in the development of lung carcinoma. (spandidos-publications.com)
  • Our data provide novel evidence that a Akt/GSK-3β/tau-dependent, but not caspase-3 signaling pathway plays a pivotal role in GT1b-mediated neurotoxic actions on mesencephalic DA neurons. (biomedcentral.com)
  • Effects of HA-ADT on the apoptotic level and AKT/GSK-3 β / β -catenin pathway in human HCC cells. (bioz.com)
  • We investigated the role of GSK-3 and the existence of an Akt-resistant pathway for GSK-3 activation in prostate cancer cells. (oncotarget.com)
  • GSK-3 has two isoforms GSK-3α and GSK-3β (17) both of which are implicated in many different biological processes including metabolism transcription translation cell growth and apoptosis (18). (cancer-ecosystem.com)
  • Although a number of studies have demonstrated that GSK-3 plays a critical role in several cellular processes, such as differentiation, growth, and apoptosis, the effects of GSK-3 on platelet production have not been explored. (elsevierpure.com)
  • Frustrated by the realization that our progress was incremental, I lead an interdisciplinary, international team to develop a new class of small molecule therapeutics that target mixed lineage kinases. (rochester.edu)
  • The majority of mutated residues were in the kinase domain, with frequent mutations occurring in a GSK-3B substrate binding pocket. (providence.org)
  • Overall, GSK-3B molecular alterations were detected in approximately 1% of solid tumors, tumors with GSK-3B mutations displayed a microenvironment with increased infiltration of B cells, and GSK-3B mutations were associated with increased PD-L1 expression in selected histologies. (providence.org)
  • The Phospho-GSK-3β (Ser9) Matched Antibody Pair is ideal for use with immunoassay technologies and high-throughput ELISA platforms requiring antibody pairs with specialized or custom antibody labeling. (cellsignal.com)
  • Glycogen synthase kinase-3 (GSK-3) and beta-catenin: potential novel therapeutic targets for COPD. (rug.nl)
  • Glycogen synthase kinase-3β (GSK-3β) is a promising target for therapeutic invasion of Alzheimer's disease (AD). (unboundmedicine.com)
  • GSK-3ß is a potentially important therapeutic target in human malignancies. (fredhutch.org)
  • Therefore we investigated the role of GSK-3β in RANKL-mediated osteoclast differentiation and also clarified the relevance of GSK-3β and NFATc1. (cancer-ecosystem.com)
  • Researchers from Temple University discovered that glycogen synthase kinase-three alpha (GSK-3 alpha) is an overall regulator of aging in many different cell types. (bioworld.com)
  • In the absence of Wnt signals, the cytoplasmic catenin beta-1 ( β-catenin ) is associated with a complex including auxin, glycogen synthase kinase 3 ( GSK-3 ), and adenomatous polyposis coli ( APC ) (the APC protein acts as the primary regulator of β-catenin function). (hindawi.com)
  • However the significance of the ability of GSK-3β to regulate NFATc1 during osteoclastogenesis has not yet been demonstrated. (cancer-ecosystem.com)
  • GSK-3 has been shown to regulate cyclin D1 proteolysis and subcellular localization (5). (cellsignal.com)
  • Moreover, Akt links a host of upstream signaling molecules to axon development, axon growth, and dendrite NBI-74330 elongation in the central nervous system (CNS) by activating mTORC1 and S6 kinase, which regulate cap-dependent protein translation, and by inhibiting TSC1/224C27. (estme.org)
  • We have previously reported reduced GSK-3β protein levels and GSK-3 total (α+β isoforms) activity in postmortem frontal cortex of schizophrenic patients. (johnshopkins.edu)
  • There are two GSK-3 isoforms, GSK-3α and GSK-3β. (elsevierpure.com)
  • For instance, some studies have suggested that in addition to antioxidant enzymes, nitric oxide synthases (NOSs), and other traditional enzymes, novel molecular targets such as mitochondria-targeting hydrogen sulfide (H 2 S) donor AP39 and its auxiliary targets have recently been identified as critical participants in H 2 S synthesis for modulating the postischemic cardiomyocyte survival in a manner independent of classical cytosolic signaling mechanisms [ 7 , 8 ]. (hindawi.com)
  • Tumor sequencing has revealed genomic alterations in GSK-3B, yet an assessment of the genomic landscape in malignancies is lacking. (providence.org)
  • Recent studies suggest a positive correlation between glycogen synthase kinase-3 (GSK-3) activation and tumor growth. (oncotarget.com)
  • Therefore, it is the need of the day to properly understand functions and mechanisms of GSK-3, especially its role in glucose homeostasis via effects on glycogen synthase. (scielo.br)
  • However, while myocardial reperfusion is well established, the process itself can trigger myocardial reperfusion injury by causing further cardiomyocyte death through multiple pathophysiological mechanisms [ 3 - 5 ]. (hindawi.com)
  • Total GSK-3 (α+β) activity was not different between lesioned and sham rats at any age. (johnshopkins.edu)
  • Changes in the activity of PP1g2 and GSK-3 are key events in sperm motility development. (kent.edu)
  • e) Western blotting was used to determine the protein levels of AKT, p-AKT, GSK-3 β , p-GSK-3 β , β -catenin, and p- β -catenin. (bioz.com)
  • Our data further confirm that caspase-3 is not a major effector of DA neuronal death in GT1b neurotoxicity. (biomedcentral.com)
  • They are 3-dimensional, complex, multicellular structures that can be derived from patient specific human induced pluripotent stem cells (hiPSCs). (nature.com)
  • Synovial apoptotic cell burden was assessed by immunofluorescence for cleaved caspase-3. (bvsalud.org)
  • These results demonstrate that reduced frontal cortical GSK-3β levels may occur as a result of neonatal hippocampal damage and suggest that this animal model may be utilized to study the mechanism of GSK-3 reduction in schizophrenia, a disorder in which postmortem changes in GSK-3 were found. (johnshopkins.edu)
  • These findings demonstrate a novel role for GSK-3β in the regulation of bone remodeling through modulation of NFATc1 in RANKL signaling. (cancer-ecosystem.com)
  • The frequency of PD-L1 expression was higher among GSK-3B-mutated tumors compared to wild-type in colorectal cancer(p=0.03), endometrial cancer(p=0.05), melanoma(p=0.02), ovarian carcinoma(p=0.0001), and uterine sarcoma(p=0.002). (providence.org)
  • In a previous report, we identified the role of glycogen synthase kinase-3β (GSK-3β) in NF-κB activation by regulating IKKγ/NEMO. (mdpi.com)
  • In addition because GSK-3β-deficient mice die (23) the relevance of GSK-3β in osteoclast precursors has not been well characterized. (cancer-ecosystem.com)
  • Forced protein kinase B/Akt 1 activation is known to induce myocyte hypertrophy in other muscle types, and, since a number of mediators present in asthmatic airways can activate Akt signaling, we hypothesized that Akt activation could contribute to ASM hypertrophy in asthma. (nih.gov)
  • GSK-3B expression and immune cell infiltrate data was analyzed across cancer types, and PD-L1 expression was compared between GSK-3B-mutated and wild-type tumors. (providence.org)
  • GSK-3B mRNA expression was highest in melanoma. (providence.org)
  • Among the dementia-linked genes with altered expression were glycogen synthase kinase 3β (GSK-3β) protein phosphatase 2 A (PP2A), and APC, which are scaffolds mediating presenilin-1/β-catenin interactions. (alzforum.org)
  • Significant differences across cancer types for GSK-3B-mutated tumors were observed for B cells (p=0.018), monocytes (p=0.002), dendritic cells (p=0.005), neutrophils (p=0.0003), and endothelial cells(p=0.014). (providence.org)
  • Alveolar type II (ATII) epithelial cells synthesize, secrete and recycle all components of surfactant and dysfunction in surfactant metabolism can result in a variety of pediatric lung diseases including respiratory distress syndrome and interstitial lung disease 3 . (nature.com)
  • Infection of iPSCs with lentiviral inserts is a highly efficient process since stem cells grow quickly, remain undifferentiated in specific cell culture conditions and can establish fully infected clones within 2-3 passages. (nature.com)
  • MSCs are multipotent stem cells with the ability to self-renew and differentiate in multiple directions [ 3 ]. (biomedcentral.com)